Default Category
-
The Novartis Malaria Initiative
Chu, Michael; Dessain, Vincent; Billaud, EmilieCase HBS-314103-EBusiness Ethics and Corporate Social ResponsibilityThe Novartis Malaria Initiative was designed, as a result of a precedent-setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria-"at no profit"-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of the anti-malaria...Starting at €8.20
-
China: "To Get Rich Is Glorious," Teaching Note
Vietor, Richard H.K.; Dessain, VincentTeaching Note HBS-708008-EEconomicsTeaching Note to 707022.Starting at €0.00
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Pearson Affordable Learning Fund
Chu, Michael; Dessain, Vincent; Maslauskaite, KristinaCase HBS-315109-EAn in-house venture capital fund for affordable private schools at the base of the pyramid established by Pearson, the world's largest education company, PALF sought to invest in business models providing superior educational outcomes in emerging markets on a profitable and scalable basis. With Pearson's overall strategy shifting from the developed to the developing world and from a supplier of books to a host of other learning products and servi...Starting at €8.20
-
La Roche-Posay: Growing L'Or al's Active Cosmetics Brand
Avery, Jill; Dessain, Vincent; Hjortshoej, Mette FuglsangCase HBS-520035-EMarketingAs 2018 neared its end, Laetitia Toupet, international general manager of L'Or al's La Roche-Posay brand reflected on the brand's achievements over the past year. At 1 billion in revenue, La Roche-Posay had recently become the number one dermocosmetics brand in the world. While Toupet was pleased with this feat, she believed that the brand was at a critical juncture. It was time to make some significant marketing decisions related to brand po...Starting at €8.20